One-quarter of patients in pharmacogenomics trial have had prescriptions changed Around 25% of the 400 participants of the 'Progress programme' have been advised to change their prescription following genetic testing.…
Adverse drug reaction profiles vary between Europe and United States Details of adverse drug reactions (ADRs) included in official product information differ significantly between the United States and Europe, according to research.…
Developing studies to test drug safety as a research fellow In her role as principal research fellow at the Drug Safety Research Unit, Deborah Layton uses principles of pharmacoepidemiology to develop studies to help assess the safety of drugs.…
